Post
Komoh
Moderna Q3 Outlook: Moderna (MRNA) is set to report its Q3 results before the US market open on Nov 6, following a net loss of approximately $800M in Q2.
Market Sentiment: Sentiment on the prediction market "Will Moderna (MRNA) beat quarterly earnings?" leans heavily optimistic, with 94% voting "Yes" against 6% for "No" on a volume of 2.61M.
#ModernaQ3VaccineSales
Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more
Replies
No comments yet. Be the first to reply!
